COLL vs MKTX · P/E 17, rev $181.9M vs P/E 13, rev $817.1M
Collegium Pharmaceutical Inc (COLL) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the COLL and MKTX stock pages for the full models.
Not investment advice.